Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 548-555

  Sheng, Wang Huei ^a   Hung, Chien Ching ^a   Chang, Sui Yuan ^a,b   Liu, Chun Jen ^a,c   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Kao, Jia Horng ^a,c   Chen, Pei Jer ^a,c   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Clinical Laboratory Sciences and Medical Biotechnology ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; COHORT ANALYSIS; DEATH; DISEASE EXACERBATION; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; IMMUNOLOGY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84984535415     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir851     Document Type: Article

References (32)

1. Lee W. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45. (Pubitemid 27527771)
2. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:593-601. (Pubitemid 40543982)
3. Thio C, Seaberg E, Skolasky R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet 2002; 360:1921-6. (Pubitemid 35472132)
4. Lindh M, Andersson A, Gusdal A. Genotypes and geographic origin of hepatitis B virus: large-scale analysis using a new genotyping method. J Infect Dis 1997; 175:1285-93. (Pubitemid 27225029)
5. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003; 46:329-38. (Pubitemid 38037030)
6. Chu C, Lok A. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35:1274-6. (Pubitemid 34454026)
7. Sanchez-Tapias J, Costa J, Mas A, et al. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients. Gastroenterology 2002; 123:1848-56. (Pubitemid 35408309)
8. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 118:554-9.
9. Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 2002; 17:165-70. (Pubitemid 34415669)
10. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol 2004; 72:363-9.
11. Chu C, Keeffe E, Han S, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38: 619-28. (Pubitemid 37055449)
12. Grandjacques C, Pradat P, Stuyvert L, et al. Rapid detection of genotypes and mutations in the basal core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 2000; 33:430-9. (Pubitemid 30663381)
13. Soriano V, Mocroft A, Peters L, et al. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 2010; 65:548-55.
14. Ramos B, Nunez M, Martín-Carbonero L, et al. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B viruscoinfected patients. J Acquir Immune Defic Syndr 2007; 44:557-61. (Pubitemid 46594899)
15. Jain MK, Comanor L, White C, et al. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. J Viral Hepat 2007; 14:176-82.
16. Lacombe K, Massari V, Girard PM, et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 2006; 20:419-27.
17. Sun HY, Ko WC, Tsai JJ, et al. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009; 104:877-84.
18. Sheng WH, Kao JH, Chen PJ, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007; 45:1221-9.
19. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004; 41:659-66.
20. Hsieh TH, Tseng TC, Liu CJ, et al. Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C. Antivir Ther 2009; 14:1157-63.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-9.
22. Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int 2005; 25:1097-107.
23. Yuen MF, Tanaka Y, Lai CL. Hepatitis B genotypes in chronic hepatitis B and lamivudine therapy. Intervirology 2003; 46:373-6. (Pubitemid 38037037)
24. FujieH,Moriya K, Shintani Y, YotsuyanagiH, Iino S,Koike K. HepatitisB virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology 2001; 120:1564-5. (Pubitemid 32322335)
25. Yuen MF, Sablon E, Wong DK, et al. Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 2003; 37: 593-7. (Pubitemid 37011785)
26. Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122:1756-62. (Pubitemid 34651418)
27. Rodriguez-Frias F, Buti M, Jardi R, et al. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995; 22:1641-7.
28. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124:327-34.
29. Kao JH, Chen PJ, Lai MY, Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 2002; 40:22-5.
30. Cooley L, Ayres A, Bartholomeusz A, et al. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIVHBV co-infected individuals. AIDS 2003; 17:1649-57. (Pubitemid 36957907)
31. Benhamou Y, Bochet M, Thibault V, et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus infected patients. Hepatology 1999; 30:1302-6. (Pubitemid 29510871)
32. Iacomi F, Vincenti D, Vairo F, et al. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B. J Med Virol 2009; 81:1151-6.